Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Amgen
About
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
- 10001 - max
Highlights
Details
- Industries
- Biotechnology,Health Care,Manufacturing,Pharmaceutical
- Founded date
- Jan 1, 1980
- Number Of Employee
- 10001 - max
- Operating Status
- Active
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases. The company is values-based and deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious diseases. They offer products for treating illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 11, 2022
Neumora Therapeutics
|
Series B | $112M | Biotechnology | — |
|
Sep 19, 2022
Motion
|
Series A | $13M | Analytics | — |
|
May 25, 2022
Meter
|
Series B | $38M | Information Technology | — |
|
May 12, 2022
TipTop
|
Series A | $23M | Cryptocurrency | — |
|
Apr 14, 2022
|
Seed | $19.50M | Apps | Yes |
Acquisition
Amgen has acquired 1 organizations. Their most recent acquisition was Horizon Pharma on Dec 12, 2022. They acquired Horizon Pharma for $27.80B.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Dec 12, 2022
Horizon Pharma
|
Biopharma | acquisition | $ 27.80B | Detail |
